CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Birmingham, Alabama, United States and 75 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Birmingham, Alabama, United States and 215 other locations
dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...
Phase 1, Phase 2
Birmingham, Alabama, United States and 104 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Birmingham, Alabama, United States and 67 other locations
in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus za...
Phase 3
Birmingham, Alabama, United States and 149 other locations
choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy....
Phase 3
Birmingham, Alabama, United States and 153 other locations
trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two phases. The primary object...
Phase 1, Phase 2
Birmingham, Alabama, United States and 22 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Birmingham, Alabama, United States and 37 other locations
pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas...
Phase 1, Phase 2
Birmingham, Alabama, United States and 34 other locations
This is an open label, multi-cohort, and multi-center phase II study, which evaluates the clinical activity and safety of IPH4102 in Sezary Syndrome...
Phase 2
Birmingham, Alabama, United States and 52 other locations
Clinical trials
Research sites
Resources
Legal